32.97

1.54% 0.4999

Hims Hers Health Inc (HIMS)

Overview News Price History Option Chain Financials Why HIMS Down? Discussions Forecast

Hims Hers Health Inc stock is traded at $32.97, with a volume of 5.56M. It is up +1.54% in the last 24 hours and down -9.20% over the past month. Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Previous Close:

$32.47

Open:

$33

24h Volume:

5.56M

Relative Volume:

0.25

Market Cap:

$7.51B

Revenue:

$1.78B

Net Income/Loss:

$164.40M

P/E Ratio:

47.78

EPS:

0.69

Net Cash Flow:

$236.51M

1W Performance:

-3.91%

1M Performance:

-9.20%

6M Performance:

-30.53%

1Y Performance:

+30.83%

1-Day Range:

$32.05

$33.25

1-Week Range:

$32.05

$34.75

52-Week Range:

$23.97

$72.98

Hims Hers Health Inc Stock (HIMS) Company Profile

Name

Hims Hers Health Inc

Sector

Healthcare (1131)

Industry

Drug Manufacturers - Specialty & Generic (85)

Phone

415-851-0195

Address

2269 CHESTNUT ST, SAN FRANCISCO

Employee

1,637

Twitter

Next Earnings Date

2025-02-24

Latest SEC Filings

HIMS's Discussions on Twitter

Compare HIMS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HIMS Hims Hers Health Inc	32.98	7.39B	1.78B	164.40M	236.51M	0.69
ZTS Zoetis Inc	125.86	55.45B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	15.63	49.25B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.02	45.02B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	30.56	35.81B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	491.07	20.98B	3.08B	1.24B	1.07B	25.61

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-25	Initiated	Barclays	Overweight
Oct-21-25	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy
Apr-29-25	Downgrade	TD Cowen	Buy → Hold
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-10-25	Downgrade	Citigroup	Neutral → Sell
Jan-07-25	Initiated	BTIG Research	Buy
Dec-17-24	Initiated	Morgan Stanley	Overweight
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral
Apr-16-24	Downgrade	Jefferies	Buy → Hold
Apr-10-24	Initiated	Canaccord Genuity	Buy
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform
Feb-26-24	Initiated	Leerink Partners	Market Perform
Dec-07-23	Initiated	Imperial Capital	In-line
Jul-28-23	Initiated	TD Cowen	Outperform
Apr-11-23	Initiated	Robert W. Baird	Neutral
Feb-09-23	Upgrade	Jefferies	Hold → Buy
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform
Oct-17-22	Downgrade	Piper Sandler	Overweight → Neutral
Sep-07-22	Initiated	Truist	Hold
Jul-15-22	Initiated	SVB Leerink	Underperform
Apr-14-22	Initiated	Guggenheim	Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Mar-10-22	Initiated	Deutsche Bank	Hold
Dec-02-21	Initiated	Jefferies	Hold
Nov-11-21	Upgrade	Piper Sandler	Neutral → Overweight
Jul-06-21	Initiated	BofA Securities	Neutral
May-20-21	Upgrade	Credit Suisse	Neutral → Outperform
Apr-21-21	Initiated	Truist	Hold
Mar-09-21	Initiated	Credit Suisse	Neutral
Mar-02-21	Upgrade	Citigroup	Neutral → Buy
Feb-17-21	Initiated	Citigroup	Neutral
Feb-12-21	Initiated	Piper Sandler	Neutral
Feb-08-21	Initiated	Tigress Financial	Buy

View All

Hims Hers Health Inc Stock (HIMS) Latest News

10:00 AM

Mixed options sentiment in Hims and Hers Health with shares down 2.47% - Yahoo Finance

Jan 01, 2026

Healthcare Stocks To ConsiderJanuary 1st - MarketBeat

Jan 01, 2026

HIMS Stock Falls -8.7% With A 7-day Losing Spree On Valuation Concerns - Trefis

Jan 01, 2026

Dec 31, 2025

How Hims & Hers Health Inc. Class A (HIMS) Affects Rotational Strategy Timing - Stock Traders Daily

Dec 31, 2025

Best Healthcare Stocks Worth WatchingDecember 28th - MarketBeat

Dec 31, 2025

Healthcare Stocks To Watch TodayDecember 31st - MarketBeat

Dec 31, 2025

Unpacking the Latest Options Trading Trends in Hims & Hers Health - Benzinga

Dec 31, 2025

Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus - ts2.tech

Dec 31, 2025

Dec 30, 2025

Hims & Hers Faces Investor Scrutiny Amid Profitability Concerns - AD HOC NEWS

Dec 30, 2025